Testing a treatment plan built for each person's tumor in children and young adults whose medulloblastoma or ependymoma has come back
Original title: Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a study in people that is still checking whether the approach can be done at all.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether a care team can build a treatment plan that fits one person's own tumor.
Who this trial is for. This trial is for children and young adults whose medulloblastoma or ependymoma has come back. It tests tumor tissue taken during surgery against drugs, looks at the tumor's genes, and then has a specialist tumor board pick a treatment plan from what they learn.
Where it stands. This trial has not reported results. It is looking at whether this approach can even be done in real time. That means testing the tissue quickly and having the tumor board assign a plan. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Someone who fits this picture could ask their care team about this study. It is a way doctors are trying to match treatment to one person's tumor. Whether anyone can join is decided by the trial team.
What it doesn't mean: This does not mean the approach works. A trial is a test, not a proven treatment. Being in one is not a guarantee that it will help. It is not a promise of a cure.
Source: ClinicalTrials.gov, August 11, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.